SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

Correspondence 0001213900-24-110153 from Health In Tech, Inc. (HIT)

Health In Tech, Inc.
Date: Dec. 18, 2024 · CIK: 0002019505 · Accession: 0001213900-24-110153

Offering / Registration Process Regulatory Compliance Financial Reporting

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-281853

Date
Dec. 18, 2024
Author
American Trust Investment Services
Form
CORRESP
Company
Health In Tech, Inc.

Letter

Re: Health In Tech, Inc.

December 18, 2024

VIA EDGAR

U.S. Securities and Exchange Commission

Division of Corporation Finance

F Street, N.E.

Washington, D.C. 20549

Registration Statement on Form S-1 (File No. 333-281853) (the “Registration Statement”)

Request for Acceleration of Effective Date

Ladies and Gentlemen:

In accordance with Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended, (the “Act”), American Trust Investment Services, Inc. as representative of the underwriters of the offering, hereby joins the Company’s request for acceleration of the above-referenced Registration Statement, requesting effectiveness for 4:00 p.m., Eastern Time on December 19, 2024, or as soon thereafter as practicable.

Pursuant to Rule 460 under the Securities Act, please be advised that the underwriters have distributed as many copies of the preliminary prospectus dated November 19, 2024 (the “Preliminary Prospectus”) to prospective underwriters and dealers, institutional investors, retail investors and others as appears to be reasonable to secure adequate distribution of the Preliminary Prospectus.

The undersigned confirms that it has complied with and will continue to comply with, and it has been informed or will be informed by participating dealers that they have complied with or will comply with, Rule 15c2-8 promulgated under the Securities Exchange Act of 1934, as amended, in connection with the above-referenced issue.

If you have any questions regarding this request, please contact our counsel John P. Yung of Lewis Brisbois Bisgaard & Smith LLP at (916)-646-8288.

Very truly yours,
American Trust Investment Services

Show Raw Text
CORRESP
1
filename1.htm

December
18, 2024

VIA
EDGAR

U.S.
Securities and Exchange Commission

Division
of Corporation Finance

100
F Street, N.E.

Washington,
D.C. 20549

    Re:
    Health In
    Tech, Inc.

    Registration Statement
    on Form S-1 (File No. 333-281853) (the “Registration Statement”)

    Request for Acceleration
    of Effective Date

Ladies
and Gentlemen:

In
accordance with Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended, (the “Act”),
American Trust Investment Services, Inc. as representative of the underwriters of the offering, hereby joins the Company’s request
for acceleration of the above-referenced Registration Statement, requesting effectiveness for 4:00 p.m., Eastern Time on December 19,
2024, or as soon thereafter as practicable.

Pursuant
to Rule 460 under the Securities Act, please be advised that the underwriters have distributed as many copies of the preliminary prospectus
dated November 19, 2024 (the “Preliminary Prospectus”) to prospective underwriters and dealers, institutional investors,
retail investors and others as appears to be reasonable to secure adequate distribution of the Preliminary Prospectus.

The
undersigned confirms that it has complied with and will continue to comply with, and it has been informed or will be informed by participating
dealers that they have complied with or will comply with, Rule 15c2-8 promulgated under the Securities Exchange Act of 1934, as amended,
in connection with the above-referenced issue.

If
you have any questions regarding this request, please contact our counsel John P. Yung of Lewis Brisbois Bisgaard & Smith LLP at
(916)-646-8288.

    Very truly yours,

    American Trust Investment Services

    By:
    /s/ Kristopher Kessler

    Name:
    Kristopher Kessler

    Title:
    Managing Director, Investment Banking